Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$209.01 - $232.56 $836 - $930
4 Added 0.36%
1,101 $240,000
Q4 2023

Jan 23, 2024

BUY
$197.69 - $227.29 $593 - $681
3 Added 0.27%
1,097 $249,000
Q3 2023

Oct 23, 2023

BUY
$201.05 - $221.7 $804 - $886
4 Added 0.37%
1,094 $219,000
Q2 2023

Jul 28, 2023

BUY
$211.93 - $241.33 $847 - $965
4 Added 0.37%
1,090 $263,000
Q1 2023

Apr 26, 2023

BUY
$213.32 - $257.83 $639 - $773
3 Added 0.28%
1,086 $249,000
Q4 2022

Jan 24, 2023

BUY
$203.72 - $248.97 $611 - $746
3 Added 0.28%
1,083 $0
Q3 2022

Oct 21, 2022

BUY
$204.81 - $262.19 $819 - $1,048
4 Added 0.37%
1,080 $221,000
Q2 2022

Aug 02, 2022

BUY
$213.86 - $277.87 $641 - $833
3 Added 0.28%
1,076 $252,000
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $200,554 - $230,072
1,073 New
1,073 $218,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Satovsky Asset Management LLC Portfolio

Follow Satovsky Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Satovsky Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Satovsky Asset Management LLC with notifications on news.